 |
|
| news |
| | LIFE & BRAIN becomes a certified service provider for Illumina Inc. |
| Bonn--August, 2008 – LIFE & BRAIN GmbH today announced that it is the | | more ... |
|
|
|
|
|
| LIFE & BRAIN becomes a certified service provider for Illumina Inc. | 13.08.2008 |
| |
Bonn--August, 2008 – LIFE & BRAIN GmbH today announced that it is the first company in Germany to become a certified service provider (CSPro(R)) for Illumina Inc. (San Diego). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. LIFE & BRAIN offers its customers whole-genome genotyping services using Illumina's Infinium(R) Assay. The Infinium HD (High-Density) product line provides researchers with the ability to perform large-scale interrogation of the human genome to cost-effectively fast forward their research and identify genetic variants linked to disease.
"Our mission is to delineate the molecular pathogenesis of common diseases and to develop specific diagnostic and therapeutic tools," said Sven Cichon, Ph.D., Head of the Molecular Genetics Laboratory at LIFE & BRAIN. "By becoming an Illumina CSPro, we are demonstrating our commitment to our customers by offering them access to the highest quality genetic analysis services."
Illumina CSPro participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.
About LIFE & BRAIN
Combining expertise in genomics, transgenics, cellomics, and cognitive neuroscience, LIFE & BRAIN represents a center of excellence in the field of translational biomedicine. Representing one of LIFE & BRAIN's R&D platforms, the Department of Genomics focuses on the identification of genetic factors that are involved in the development of human complex diseases.
About Illumina
Illumina is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the large-scale analysis of genetic variation and biological function. Using proprietary technologies, Illumina provides a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and Illumina expects to enter the market for molecular diagnostics.
|
|
|
